Patrick Machado - 14 Jun 2022 Form 4 Insider Report for Arcus Biosciences, Inc. (RCUS)

Role: Director
Signature: /s/ Carolyn Tang, Attorney-in-Fact
Issuer symbol: RCUS
Transactions as of: 14 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 16 Jun 2022, 16:26:38 UTC
Previous filing: 14 Jun 2022
Next filing: 24 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCUS	Common Stock	Award	$0	+4,100	+68%	$0.000000	10,100	14 Jun 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCUS	Stock Option (Right to Buy)	Award	$0	+16,800		$0.000000	16,800	14 Jun 2022	Common Stock	16,800	$20.62	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of restricted stock units that vest in full on the earlier of June 14, 2023 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
F2	Includes 3,000 shares of restricted stock units (previously reported) that vested on June 3, 2022.
F3	The option will vest in full on the earlier of June 14, 2023 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.